🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Ehlers-Danlos Syndrome on Gynaecological Health

Recruitingn/aAges 18 Years - 50 YearsFemaleUniversity Hospital, Rouen
NCT07151274 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Dysmenorrhea is a common problem in gynaecology, significantly impacting patients' quality of life. Ehlers-Danlos syndrome (EDS) is associated with joint hypermobility, tissue fragility and chronic pain. Some studies suggest an increased prevalence of gynaecological disorders, including dysmenorrhea, in patients with EDS. However, data remain limited and few studies have compared the intensity and characteristics of dysmenorrhea in women with EDS. There is also little data on the prevalence of other gynaecological conditions in women with EDS. This study therefore aims to compare the severity of dysmenorrhea in patients with EDS and a control group in order to better characterise the gynaecological impact of EDS. It will also compare the prevalence of other gynaecological conditions between women with EDS and women without EDS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women aged 18 or over. * Willing to participate voluntarily in the study via an online questionnaire. * Of childbearing age. * Reporting a diagnosis of EDS (all types) or not having EDS (control group) and being part of a database of healthy volunteers. Exclusion Criteria: * Minors (\< 18 years old). * Menopausal women * People who do not understand French well enough to complete the questionnaire. * Uncertain diagnosis of EDS (exclusion of participants who suspect EDS but without medical confirmation).
💊

What it tests

  • Not listed
📍

Where

1 site
CHU de ROUEN
Rouen, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy